Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lattmann

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Drug Discoveries & Therapeutics|April 17, 2012
Part 2. Long term in vivo/in vitro evaluation of the Cholecystokinin antagonists: N-(5-methyl-3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylurea MPP and carboxamide MPME Lattmann, Y Boonprakob, J Sattayasai
Drug Design and Discovery|January 7, 2000
Design and synthesis of stable, water soluble radicals as potential anti-cancer agentsE Lattmann, A Begum, M J Plater
European Journal of Immunology|June 1, 1976
Immunologic induction of reticulum cell sarcoma: donor-type lymphomas in the graft-versus-host modelE Gleichmann, K Peters, E Lattmann, et al.
Drug Design and Discovery|January 7, 2000
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part One: Construction of a sub-library of halogenated 5-alkoxy-2(5H)-furanonesE Lattmann, D C Billington, C A Langley
Drug Design and Discovery|January 7, 2000
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part Two: Construction of a library of 4-amino-5-alkoxy-2(5H)-furanonesE Lattmann, D C Billington, C A Langley
Journal of Microencapsulation|January 3, 2012
Trigger release liposome systems: local and remote controlled delivery?Sagida Bibi, E Lattmann, Afzal R Mohammed, et al.
Zentralblatt Fur Chirurgie|January 1, 1984
[Intraoperative pancreas puncture cytology]A Eggert, E Lattmann, R Kopf, et al.
Drug Discoveries & Therapeutics|April 17, 2012
Cholecystokinin antagonists (part 1): Antinociceptive, anxiolytic and antidepressant effects of N-(5-methyl-3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylureas and carboxamidesE Lattmann, J Sattayasai, Y Boonprakob, et al.
Drug Discoveries & Therapeutics|March 31, 2012
Identification and evaluation of agents isolated from traditionally used herbs against Ophiophagus hannah venomR Salama, J Sattayasai, A K Gande, et al.
Drug Design and Discovery|July 27, 2001
Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonistsE Lattmann, D C Billington, D R Poyner, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Drug Discoveries & Therapeutics|April 17, 2012
Part 2. Long term in vivo/in vitro evaluation of the Cholecystokinin antagonists: N-(5-methyl-3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylurea MPP and carboxamide MPME Lattmann, Y Boonprakob, J Sattayasai
Drug Design and Discovery|January 7, 2000
Design and synthesis of stable, water soluble radicals as potential anti-cancer agentsE Lattmann, A Begum, M J Plater
European Journal of Immunology|June 1, 1976
Immunologic induction of reticulum cell sarcoma: donor-type lymphomas in the graft-versus-host modelE Gleichmann, K Peters, E Lattmann, et al.
Drug Design and Discovery|January 7, 2000
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part One: Construction of a sub-library of halogenated 5-alkoxy-2(5H)-furanonesE Lattmann, D C Billington, C A Langley
Drug Design and Discovery|January 7, 2000
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part Two: Construction of a library of 4-amino-5-alkoxy-2(5H)-furanonesE Lattmann, D C Billington, C A Langley
Journal of Microencapsulation|January 3, 2012
Trigger release liposome systems: local and remote controlled delivery?Sagida Bibi, E Lattmann, Afzal R Mohammed, et al.
Zentralblatt Fur Chirurgie|January 1, 1984
[Intraoperative pancreas puncture cytology]A Eggert, E Lattmann, R Kopf, et al.
Drug Discoveries & Therapeutics|April 17, 2012
Cholecystokinin antagonists (part 1): Antinociceptive, anxiolytic and antidepressant effects of N-(5-methyl-3-oxo-1,2-diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylureas and carboxamidesE Lattmann, J Sattayasai, Y Boonprakob, et al.
Drug Discoveries & Therapeutics|March 31, 2012
Identification and evaluation of agents isolated from traditionally used herbs against Ophiophagus hannah venomR Salama, J Sattayasai, A K Gande, et al.
Drug Design and Discovery|July 27, 2001
Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonistsE Lattmann, D C Billington, D R Poyner, et al.
Pageof 2